The Evolving Treatment Landscape for Myelofibrosis - Episode 5

Ruxolitinib Combination Therapies for Myeloproliferative Neoplasms

Dr Pemmaraju explains the rationale for ruxolitinib combination therapies in myeloproliferative neoplasm treatment.